OliX Pharmaceuticals, Inc (KOSDAQ:226950)
92,200
-1,800 (-1.91%)
Nov 2, 2026, 12:59 PM KST
| Market Cap | 2.10T +7.1% |
| Revenue (ttm) | 13.64B +80.9% |
| Net Income | -14.03B |
| EPS | -662.93 |
| Shares Out | 22.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 85,755 |
| Open | 94,000 |
| Previous Close | 94,000 |
| Day's Range | 90,600 - 95,900 |
| 52-Week Range | 84,300 - 217,000 |
| Beta | 0.44 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |